2017
DOI: 10.1016/j.ijtb.2016.09.018
|View full text |Cite
|
Sign up to set email alerts
|

Multidrug resistant tuberculosis during pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“… 38 There are limited data regarding the use of many of the second-line drugs in pregnant people, 39 as there has not been fair inclusion in most RR/MDR-TB clinical trials, including those establishing the safety and efficacy of all-oral regimens. 40 This is unfortunate as the older standard regimens (e.g., containing ethionamide or injectable agents) are toxic to both pregnant people and their fetus. 41 However, there are emerging data from cohort studies that demonstrate the safety of many second-line drugs in pregnancy.…”
Section: Best Clinical Practice For Pregnant People With Tbmentioning
confidence: 99%
“… 38 There are limited data regarding the use of many of the second-line drugs in pregnant people, 39 as there has not been fair inclusion in most RR/MDR-TB clinical trials, including those establishing the safety and efficacy of all-oral regimens. 40 This is unfortunate as the older standard regimens (e.g., containing ethionamide or injectable agents) are toxic to both pregnant people and their fetus. 41 However, there are emerging data from cohort studies that demonstrate the safety of many second-line drugs in pregnancy.…”
Section: Best Clinical Practice For Pregnant People With Tbmentioning
confidence: 99%